Trademark: 79329099
Word
EMPRANDO
Status
Registered
Status Code
700
Status Date
Tuesday, December 20, 2022
Serial Number
79329099
Registration Number
6926967
Registration Date
Tuesday, December 20, 2022
Mark Type
4000
Filing Date
Monday, October 25, 2021
Published for Opposition
Tuesday, October 4, 2022

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; vaccines
10 Medical injection devices for the administration of pharmaceutical preparations for the delivery of anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical preparations, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases, pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the prevention and treatment of eye diseases and conditions, pharmaceutical preparations for the prevention and treatment of heart rhythm disorders, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of kidney diseases, pharmaceutical preparations for the prevention and treatment of diabetes, pharmaceutical preparations for the prevention and treatment of hypertension, pharmaceutical preparations for the prevention and treatment of skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical preparations for use in ophthalmology, pharmaceutical preparations for the prevention and treatment of cancer and tumors, pharmaceutical preparations for the prevention and treatment of allergies, pharmaceutical preparations for the prevention and treatment of bone diseases, pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma and vaccines

Trademark Events
Apr 24, 2023
Final Decision Transaction Processed By Ib
Apr 5, 2023
Final Disposition Notice Sent To Ib
Apr 5, 2023
Final Disposition Processed
Mar 20, 2023
Final Disposition Notice Created, To Be Sent To Ib
Dec 20, 2022
Notice Of Registration Confirmation Emailed
Dec 20, 2022
Registered-Principal Register
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Oct 3, 2022
Notification Processed By Ib
Sep 14, 2022
Notification Of Possible Opposition Sent To Ib
Sep 14, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 31, 2022
Approved For Pub - Principal Register
Aug 16, 2022
Assigned To Examiner
Jul 27, 2022
Teas/Email Correspondence Entered
Jul 27, 2022
Correspondence Received In Law Office
Jul 27, 2022
Teas Response To Office Action Received
Mar 27, 2022
Refusal Processed By Ib
Mar 8, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 8, 2022
Refusal Processed By Mpu
Feb 9, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 8, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Jan 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 26, 2022
Teas Change Of Correspondence Received
Jan 26, 2022
Teas Change Of Domestic Representatives Address
Jan 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2022
Teas Change Of Owner Address Received
Jan 11, 2022
Application Filing Receipt Mailed
Jan 7, 2022
New Application Office Supplied Data Entered
Jan 5, 2022
Limitation From Original Application Entered
Dec 23, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24